4 Third Avenue Management Supernus Pharmaceuticals Trades
Third Avenue Management acquired 160 Thousand Supernus Pharmaceuticals shares worth $4.65 Million. That's 0.76% of their equity portfolio (41st largest holding). The investor's estimated purchase price is $4.98 Million, resulting in a loss of 6.7%.
News about Supernus Pharmaceuticals Inc and Third Avenue Management
New York Life Investment Management LLC Lowers Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
New York Life Investment Management LLC decreased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 25.5% during the first quarter, ...
Mitsubishi UFJ Asset Management UK Ltd. Buys New Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Mitsubishi UFJ Asset Management UK Ltd. acquired a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) in the third quarter, according to the company i...
Radcliffe Capital Management, L.P. Buys Supernus Pharmaceuticals Inc, BlackRock Capital ...
Related Stocks: DHHC , GFX , VYGG , SUPN , BKCC , DISH , INVA , GSBD , SIERU , GACQU , CENH , GIWWU , CAP , DEH , MAAC ,